Market Place
Sourcing Support
Energesis And Akston Sign Partnership For Companion Animal Obesity Drug
20 Aug 2024 //
BUSINESSWIRE
Purdue And Akston Partner For Dog Cancer Drug Development
13 Aug 2024 //
BUSINESSWIRE
Dechra Purchases Veterinary Insulin Programs from Akston Biosciences
30 Jul 2024 //
BUSINESSWIRE
Akston`s AKS-107 Study Published in Frontiers in Ambifect Platform’s Versatility
11 Mar 2024 //
BUSINESSWIRE
Akston Biosciences to Focus on Strong Animal Health Pipeline
17 Aug 2023 //
BUSINESSWIRE
Akston Biosciences Ends Vaccine Partnership with Stelis
07 Mar 2023 //
BUSINESSWIRE
Akston Biosciences Strengthens Board with Addition of John T. Preston
23 Jan 2023 //
BUSINESSWIRE
Akston Biosciences Announces Positive Interim PhII Results COVID “Universal”
01 Nov 2022 //
BUSINESSWIRE
Biolexis and Akston Biosciences Announce Top-Line Results from PII/III Trial
24 Jun 2022 //
BUSINESSWIRE
Akston doses first subjects in Phase II Covid-19 booster trial
13 May 2022 //
CLINICALTRIALSARENA
Akston Biosciences Begins Dosing in PII Trial for Shelf-Stable COVID-19 Booster
12 May 2022 //
BUSINESSWIRE
Akston Biosciences CEO to Present at the World Vaccine Congress
12 Apr 2022 //
BUSINESSWIRE
Akston Bio Doses First Volunteers in Phase II/III Trial of COVID-19 Vaccine
07 Apr 2022 //
BUSINESSWIRE
Akston to launch Phase II trial of Covid-19 booster vaccine in Netherlands
01 Apr 2022 //
CLINICALTRIALSARENA
Akston Bio Bags Approval for Phase II Trial for Shelf-Stable COVID-19 Booster
31 Mar 2022 //
BUSINESSWIRE
Akston Bio, Biolexis Collaborate to Launch 2nd Generation COVID-19 Vaccine
17 Mar 2022 //
BUSINESSWIRE
Akston Bio to Publish in Vaccine of Positive Data for COVID-19 Vaccine
08 Feb 2022 //
BUSINESSWIRE
Akston Announces Positive Top-Line Data From Phase II Study of COVID-19 Vaccine
22 Dec 2021 //
BUSINESSWIRE
Akston doses first participants in Phase II Covid-19 vaccine trial in India
22 Nov 2021 //
CLINICALTRIALSARENA
Akston Begins Dosing in Phase II Trial in India of 2nd Gen COVID-19 Vaccine
20 Nov 2021 //
BUSINESSWIRE
Akston initiates subject dosing in Phase II Covid-19 vaccine trial
06 Aug 2021 //
CLINICALTRIALARENA
Akston Doses First Subjects in Phase II Trial of 2nd-Gen Subunit COVID-19 Jab
05 Aug 2021 //
BUSINESSWIRE
Akston Biosciences Announces Commercial Supply Agreement of Seppic’s Adjuvant
21 Jul 2021 //
BUSINESSWIRE
Akston Biosciences Announces Positive PhI Data for COVID-19 Vaccine Candidate
07 Jul 2021 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.